MET EXON 14 MUTATION

Clinical trials for MET EXON 14 MUTATION explained in plain language.

Never miss a new study

Get alerted when new MET EXON 14 MUTATION trials appear

Sign up with your email to follow new studies for MET EXON 14 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Breakthrough drug trial offers hope for Tough-to-Treat lung cancer

Disease control Recruiting now

This study is testing whether the drug tepotinib works better than standard treatments for people with advanced non-small cell lung cancer that has a specific genetic change called a MET exon 14 mutation. The trial is for patients whose cancer has worsened after at least one prio…

Matched conditions: MET EXON 14 MUTATION

Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

MET EXON 14 MUTATION

Get alerted when new MET EXON 14 MUTATION trials appear

Breakthrough drug trial offers hope for Tough-to-Treat lung cancer